Grail partnered with Epic to integrate access to the Galleri multi-cancer early detection test directly within Epic electronic health record platforms. Under the agreement, clinicians can order Galleri at the point of care through native EHR workflows and receive results within existing portals. Grail said implementation planning began in Q1 2026, with broader EHR availability expected by end of the year. The rollout aims to reduce operational barriers for health systems adopting early detection workflows, extending similar integration efforts made with other EHR and lab ordering environments. This expansion matters for adoption economics: workflow friction has been a recurring limiter for complex testing pathways, so EHR-native ordering is designed to improve test utilization and timeliness of results.